Comparison of the chromosome damage and its dose response after medical whole-body exposure to 60Co gamma-rays and irradiation of blood in vitro.
D000230:Adenocarcinoma / Q000532:radiotherapy; D000328:Adult; D000368:Aged; D001943:Breast Neoplasms / Q000532:radiotherapy; D001984:Bronchial Neoplasms / Q000532:radiotherapy; D002869:Chromosome Aberrations; D003037:Cobalt Radioisotopes / Q000627:therapeutic use; D004307:Dose-Response Relationship, Radiation; D004938:Esophageal Neoplasms / Q000532:radiotherapy; D005260:Female; D006801:Humans; D066298:In Vitro Techniques; D007822:Laryngeal Neoplasms / Q000532:radiotherapy; D008214:Lymphocytes / Q000528:radiation effects*; D008297:Male; D008875:Middle Aged; D009362:Neoplasm Metastasis; D009369:Neoplasms / Q000532:radiotherapy*; D010051:Ovarian Neoplasms / Q000532:radiotherapy; D011831:Radiation Genetics; D011867:Radioisotope Teletherapy; D011878:Radiotherapy / Q000009:adverse effects; D011879:Radiotherapy Dosage; D012004:Rectal Neoplasms / Q000532:radiotherapy; D012811:Sigmoid Neoplasms / Q000532:radiotherapy; D013964:Thyroid Neoplasms / Q000532:radiotherapy; D014067:Tonsillar Neoplasms / Q000528:radiation effects; D001749:Urinary Bladder Neoplasms / Q000532:radiotherapy
D003037:Cobalt Radioisotopes